Investeringsforeningen Wealth Invest
1.10.2026 09:00:00 CEST | Globenewswire | Press release
Offentliggørelse af prospekt, Investeringsforeningen Wealth Invest
Offentliggørelse af prospekt, Investeringsforeningen Wealth Invest
Hermed offentliggøres et ajourført prospekt for Secure Spectrum-afdelingerne i Investeringsforeningen Wealth Invest.
Prospektet er blevet ajourført som følge af en ændring i honorarstrukturen for porteføljeforvaltningshonoraret for så vidt angår afdeling Janus H High Yield Obligationer.
Prospektet er vedhæftet denne meddelelse og kan ligeledes tilgås via Foreningens hjemmeside.
For eventuelle spørgsmål kontakt Michael Frisch, direktør i foreningens investeringsforvaltningsselskab, på telefon 33 28 28 28.
Med venlig hilsen
Investeringsforeningen Wealth Invest
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Junshi Biosciences24.10.2026 05:30:32 CEST | Press release
Junshi Biosciences Announces Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS203 in Combination with Chemotherapy for the Treatment of Diffuse Large B-cell Lymphoma
SERB Pharmaceuticals23.10.2026 21:01:27 CEST | Press release
SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026
F. Hoffmann-La Roche Ltd23.10.2026 19:30:00 CEST | Press release
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
TecDo Technology Co., Limited23.10.2026 18:37:22 CEST | Press release
TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work
CGTN23.10.2026 18:17:10 CEST | Pressemeddelelse
CGTN: Hvad fortæller historien om 'Half a Quilt' (Et halvt vattæppe) os om Kinas nye lange march?
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom